Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening
NCT05480891 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3
Last updated 2025-05-25
Summary
This research study is being done for 2 reasons: 1) The investigators want to learn about the eating, smoking and drinking habits of adults, 18 years of age and older, in various Chicago communities, and 2) the investigators want to offer screening for participants whose smoking and drinking habits put them at risk for cancer.
Conditions
- Esophageal Cancer
Interventions
- PROCEDURE
-
Transnasal Esophagoscopy (TNE)
While seated in an upright position a topical numbing medicine will be sprayed in your nose and the back of your throat. A thin, flexible tube less than ¼ inch in diameter, will be placed in one of your nostrils and advanced to the back of your throat. When the tube reaches the back of the throat you will be asked to drink sips of water to help move the tube into and down the esophagus as it is advanced. The tip of the tube has a small light and camera built in that allows the doctor to see the structures of the mouth and esophagus as the tube is advanced. Once the tube is in the esophagus, the physician will examine your esophagus for any abnormal changes. Once the visual inspection is complete the tube will be gently removed through your nose. The procedure will take approximately 10-15 minutes of time.
Sponsors & Collaborators
-
Cures Within Reach
collaborator OTHER -
University of Illinois at Chicago
lead OTHER
Principal Investigators
-
H. Steven Sims, MD · University of Illinois Chicago
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-05
- Primary Completion
- 2025-03-19
- Completion
- 2025-03-19
Countries
- United States
Study Locations
More Related Trials
-
A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
NCT06523374 ·Status: RECRUITING ·Phase: NA
-
Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial?
NCT00583934 ·Status: COMPLETED
-
Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancer
NCT05450484 ·Status: COMPLETED ·Phase: PHASE1
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
Epidemiology of Barrett's Esophagus: A Population Based Study
NCT01286155 ·Status: COMPLETED
-
Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and Lung
NCT03051802 ·Status: TERMINATED ·Phase: NA
-
Non-endoscopic EC Screening Program in Northern Iran
NCT02311712 ·Status: SUSPENDED ·Phase: NA
-
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
NCT01293448 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Prevention of Esophageal Cancer at Tenwek Hospital
NCT02146508 ·Status: SUSPENDED ·Phase: NA
-
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
NCT06381583 ·Status: COMPLETED
-
Early Detection of Barrett's Esophagus
NCT00081354 ·Status: COMPLETED
-
Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
NCT06693622 ·Status: RECRUITING
-
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
NCT04293458 ·Status: COMPLETED ·Phase: NA
-
Cryotherapy for Barrett's Esophagus and Early Esophageal Cancers
NCT00650988 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer
NCT00629863 ·Status: COMPLETED ·Phase: NA
-
Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
NCT00054873 ·Status: COMPLETED ·Phase: PHASE2
-
Tissue Collection Protocol for Gastroesophageal Cancers
NCT02495337 ·Status: RECRUITING
-
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
NCT07212491 ·Status: ENROLLING_BY_INVITATION
-
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
NCT06732388 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
C2 Esophageal Squamous Epithelium Dysplasia
NCT05349240 ·Status: RECRUITING ·Phase: NA
-
Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers
NCT05688176 ·Status: RECRUITING
-
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
NCT04295811 ·Status: UNKNOWN ·Phase: NA
-
The Microenvironment in Barrett's Esophagus
NCT03060642 ·Status: COMPLETED
-
Genetic and Environmental Risk Factors Related to Esophageal Cancer
NCT01035398 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia
NCT02464930 ·Status: UNKNOWN